Aristeia Capital’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Aristeia Capital’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-687,951	Closed	-$482K	–	712
2022 Q2	$482K	Sell	687,951 -298,436	-30%	-$309K	0.01%	390
2022 Q1	$1.58M	Sell	986,387 -151,435	-13%	-$218K	0.03%	367
2021 Q4	$2.7M	Buy	1,137,822 +43,248	+4%	+$131K	0.05%	353
2021 Q3	$4.53M	Buy	1,094,574 +437,992	+67%	+$1.65M	0.08%	263
2021 Q2	$2.42M	Buy	+656,582	New	+$2.96M	0.05%	304

Other funds holding CANO.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

UFM

Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aristeia Capital's CANO.WS Position: Q3 2022 in Review

Aristeia Capital sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q3 2022, closing a stake of 687,951 shares — an estimated $482K sold.

Aristeia Capital first reported a position in CANO.WS in Q2 2021 and held it in 5 quarters. The position peaked at $4.53M in Q3 2021. 30 funds tracked by Wall St. Rank hold CANO.WS as of Q3 2022.

Aristeia Capital reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q3 2022 after selling out during the quarter.
Aristeia Capital sold 687,951 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q3 2022, an estimated $482K.
Aristeia Capital first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 5 quarters.
Aristeia Capital's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $4.53M in Q3 2021.
30 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q3 2022.

Based on Aristeia Capital's 13F filing for Q3 2022, filed 14 Nov 2022.